InvestorsHub Logo
Followers 0
Posts 58
Boards Moderated 0
Alias Born 04/06/2017

Re: blu_1 post# 4975

Tuesday, 05/16/2017 12:44:38 PM

Tuesday, May 16, 2017 12:44:38 PM

Post# of 21531
So ridiculous to call this a P&D. The value of this stock is based on the probability of Bryostatin success, you are buying a possible future, not a current reality. Same as TESLA or SNAP in the tech sector or all small cap Biotechs taking drugs through the FDA process. Its about taking a calculated risk, based on viable theory of how a particular company may be able to bring a currently none existent and unproven reality of into being and make money. The massive difference here is that, while with Tesla or Snap, there is no one piece of news which could come out tomorrow and conclusively validate the current sp valuation and on the other hand are there countless variables which may prevent that valuation from materializing. Here we are one small piece of news away from this being $100 or even $1000 per share. If tomorrow, `17 week data shows continued improvement of a point or two.. bang its a home run. If it doesn't, there are still countless variables of how this drug could prove efficiency. I.E. spesific groups of patients or in combination with other drugs etc.. The company has $25 mil in the bank and more then a million shares in reserve without the need for dilution, plenty of room to maneuver. So yes, this is a stock which could go down by 50% one day and go up 5000% on another day. That all depends on research results, and anyone investing in such a company needs to have a stomach for that kind of volatility.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News